Zobrazeno 1 - 10
of 229
pro vyhledávání: '"DAVID J ROSS"'
Publikováno v:
Biomarker Insights, Vol 15 (2020)
Externí odkaz:
https://doaj.org/article/3e1579a69f644358ab2408238c691af5
Autor:
Anna-Maria Hoffmann-Vold, Stephen Samuel Weigt, Vyacheslav Palchevskiy, Elizabeth Volkmann, Rajan Saggar, Ning Li, Øyvind Midtvedt, May Brit Lund, Torhild Garen, Michael C Fishbein, Abbas Ardehali, David J Ross, Thor Ueland, Pål Aukrust, Joseph P Lynch, Robert M Elashoff, Øyvind Molberg, John A Belperio
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0206545 (2018)
BACKGROUND:Dysregulation of Fractalkine (CX3CL1) and its receptor CX3CR1 has been linked to the pathobiology of chronic inflammatory conditions. We explored CX3CL1 in systemic sclerosis (SSc) related progressive interstitial lung disease (ILD) and pu
Externí odkaz:
https://doaj.org/article/35807d8610404e829ad34bc846b6ab31
Autor:
S Samuel Weigt, Xiaoyan Wang, Vyacheslav Palchevskiy, Aric L Gregson, Naman Patel, Ariss DerHovanessian, Michael Y Shino, David M Sayah, Shirin Birjandi, Joseph P Lynch, Rajan Saggar, Abbas Ardehali, David J Ross, Scott M Palmer, David Elashoff, John A Belperio
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0169894 (2017)
BACKGROUND:Chronic Lung Allograft Dysfunction (CLAD) is the main limitation to long-term survival after lung transplantation. Although CLAD is usually not responsive to treatment, earlier identification may improve treatment prospects. METHODS:In a n
Externí odkaz:
https://doaj.org/article/51c2cfff00ed41e99d5e67da95b3a38c
Autor:
Michael Y Shino, S Samuel Weigt, Ning Li, Vyacheslav Palchevskiy, Ariss Derhovanessian, Rajan Saggar, David M Sayah, Richard H Huynh, Aric L Gregson, Michael C Fishbein, Abbas Ardehali, David J Ross, Joseph P Lynch, Robert M Elashoff, John A Belperio
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0180281 (2017)
Since the pathogenesis of chronic lung allograft dysfunction (CLAD) remains poorly defined with no known effective therapies, the identification and study of key events which increase CLAD risk is a critical step towards improving outcomes. We hypoth
Externí odkaz:
https://doaj.org/article/f26eb751205e4bdab74fb06f6ebd3e38
Autor:
Justin P. Rosenheck, DO, David J. Ross, MD, Mena Botros, MD, Alexander Wong, MD, Jonathan Sternberg, PhD, Yen-An Chen, MS, Nathan Liang, BA, Amy Baer, MS, Ebad Ahmed, PhD, Ryan Swenerton, PhD, Bernhard G. Zimmermann, PhD, Gordon Fehringer, PhD, Zachary P. Demko, PhD, Michael Olymbios, MD, Paul R. Billings, MD, PhD, Brian C. Keller, MD, PhD
Publikováno v:
Transplantation Direct, Vol 8, Iss 4, p e1317 (2022)
Background. Lung transplant patients are vulnerable to various forms of allograft injury, whether from acute rejection (AR) (encompassing acute cellular rejection [ACR] and antibody-mediated rejection [AMR]), chronic lung allograft dysfunction (CLAD)
Externí odkaz:
https://doaj.org/article/9edea27d61424d5caf9b33424f5d3cb2
Publikováno v:
ERJ Open Research, Vol 7, Iss 1 (2021)
ERJ Open Research
article-version (VoR) Version of Record
ERJ Open Research
article-version (VoR) Version of Record
Surveillance after lung transplantation is critical to the detection of acute cellular rejection (ACR) and prevention of chronic lung allograft dysfunction (CLAD). Therefore, we measured donor-derived cell-free DNA (dd-cfDNA) implementing a clinical-
Autor:
Justin P. Rosenheck, David J. Ross, Mena Botros, Alexander Wong, Jonathan Sternberg, Yen-An Chen, Nathan Liang, Amy Baer, Ebad Ahmed, Ryan K. Swenerton, Bernhard G. Zimmermann, Gordon Fehringer, Zachary P. Demko, Michael Olymbios, Cesar Escrig, Paul R. Billings, Brian C. Keller
Publikováno v:
Transplantation. 106:S496-S497
Autor:
Gretchen Greene, Jared Ragland, Zachary Trautt, June W. Lau, Raymond Plante, Joshua Taillon, Adam Abel Creuziger, Chandler A. Becker, Joe Bennett, Niksa Blonder, Lisa Borsuk, Carelyn E. Campbell, Adam Friss, Lucas Hale, Michael Halter, Robert Hanisch, Gary R. Hardin, Lyle E. Levine, Samantha Maragh, Sierra Miller, Chris Muzny, Marcus William Newrock, John Perkins, Anne L. Plant, Bruce D. Ravel, David J. Ross, John Henry J. Scott, Christopher Szakal, Alessandro Tona, Peter Vallone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c47a82e2fe3ea032ff833938837b714
https://doi.org/10.6028/nist.tn.2216
https://doi.org/10.6028/nist.tn.2216
Publikováno v:
OBM Transplantation. 4:1-12
Biomarker surveillance after solid organ transplant is an advancing field with promise for further elucidation through high-throughput analyses and “omics” technologies. To date, Gene Expression Profiling (GEP; AlloMapâ) is the only FDA-cleared
Autor:
David J. Ross, Joseph P. Lynch, John A. Belperio, S. Samuel Weigt, Elizabeth R. Volkmann, Anna-Maria Hoffmann-Vold, Abbas Ardehali, Vyacheslav Palchevskiy, Rajan Saggar, Lloyd L. Liang
Publikováno v:
EBioMedicine
Background Some interstitial lung disease (ILD) patients develop a progressive fibrosing-ILD phenotype (PF-ILD), with similar persistent lung function decline suggesting common molecular pathways involved. Nintedanib, a tyrosine kinase inhibitor targ